Abstract
e17695 Background: The administration of adjuvant radioactive iodine (RAI) for patients with papillary thyroid cancer (PTC) is controversial. Current guidelines recommend RAI for patients at high r...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
